| 1 | DEFB103A, DEFB104A, DEFB105A, DEFB106A, DEFB107A, DEFB4A, DUP8P23, SPAG11B
|
| Psoriasis is associated with increased beta-defensin genomic copy number.
|
| Hollox EJ, Huffmeier U, Zeeuwen PL, Palla R, Lascorz J, Rodijk-Olthuis D, van de Kerkhof PC, Traupe H, de Jongh G, den Heijer M, Reis A, Armour JA, Schalkwijk J.
|
| Nat Genet 40(1):23-5. Epub 2007 Dec 2. 2008
|
| 2 | DEFA1, DEFA3, DEFA4, DEFA5, DEFA6, DEFB1, DEFB103A, DEFB4A
|
| Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha- and beta-defensin regions at 8p22-p23.
|
| Linzmeier RM, Ganz T.
|
| Genomics 86(4):423-30. 2005
|
| 3 | DEFB103A
|
| Discovery of new human beta-defensins using a genomics-based approach.
|
| Jia HP, Schutte BC, Schudy A, Linzmeier R, Guthmiller JM, Johnson GK, Tack BF, Mitros JP, Rosenthal A, Ganz T, McCray PB Jr.
|
| Gene 263(1-2):211-8. 2001
|
| 4 | DEFB103A, DEFB103B
|
| Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic.
|
| Harder J, Bartels J, Christophers E, Schroder JM.
|
| J Biol Chem 276(8):5707-13. 2001
|
| 5 | DEFB103A
|
| Inhibition of hBD-3, but not hBD-1 and hBD-2, mRNA expression by corticosteroids.
|
| Duits LA, Rademaker M, Ravensbergen B, van Sterkenburg MA, van Strijen E, Hiemstra PS, Nibbering PH.
|
| Biochem Biophys Res Commun 280(2):522-5. 2001
|